MedTrace Logo

Evaluating the Efficacy of Using a Digital Consumption Management Tool for Family Planning in Zambia

NCT05503992 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2523

Last updated 2023-12-20

No results posted yet for this study

Summary

The primary objective of this evaluation is to understand the effectiveness of the OpenSRP platform on unmet family planning (FP) demand in rural Zambia. The specific objectives are to:

1. assess the impact of the intervention on satisfaction and use of modern family planning methods among last-mile people of childbearing potential; and
2. understand the impact of the intervention on FP inventory management and dispensing.

The investigators will employ mixed-methods for data collection for this two-arm cluster-randomized trial. This effectiveness evaluation will be paired with a concurrent implementation evaluation, making it a Type 2 Hybrid Design.

For the impact evaluation data will be collected from two main sources at both baseline and endline: 1) existing stock management records (eLMIS and paper records, depending on study arm); and 2) Short phone surveys with people of childbearing potential in the community.

Conditions

  • Family Planning

Interventions

OTHER

Intervention package

The intervention package will include a mobile device configured with OpenSRP configured to facilitate clinical/service provision and stock management. The intervention also incorporates a training component on OpenSRP with accompanying follow-up supervisory visits for a limited period. Per the theory of changes, these activities will improve CHWs' knowledge and ability to use the platform for clinical care, dispensing, and workflow management, leading to an improved stock of commodities to meet preferred FP needs among last mile women.

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • Pharmaceutical Systems Africa (PSA)

    collaborator UNKNOWN

  • Boston University

    lead OTHER

Principal Investigators

  • Veronika J Wirtz, BPharm, PhD · Boston University School of Public Health, Global Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-05
Primary Completion
2023-12-01
Completion
2023-12-08

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05503992 on ClinicalTrials.gov